InMode names Michael Dennison as president of North America

InMode Ltd. (NASDAQ:INMD) has appointed Michael Dennison as President of North America, a move coinciding with restructuring efforts and leveraging his proven track record in sales and market expansion. This leadership change follows the company's preliminary third-quarter revenue exceeding analyst expectations at $92.5M-$93.0M, despite a 29% year-over-year decline, with full-year guidance maintained. While analysts like Canaccord Genuity and Needham hold a 'Hold' rating, with Canaccord raising its price target to $16, significant shareholder DOMA Perpetual Capital Management is advocating for a 20% share buyback over the next two quarters, highlighting ongoing investor interest and strategic considerations for the medical device firm.

Analysis

InMode Ltd. (INMD) has appointed Michael Dennison as President of North America, a strategic move within the company's ongoing restructuring efforts. Dennison brings a decade of experience at InMode, credited with national revenue growth and market share expansion, alongside prior leadership roles at Cynosure. This leadership change aims to accelerate momentum in the North American market.

The company reported preliminary third-quarter revenue of $92.5-$93.0 million, surpassing analyst consensus of $88.1 million, yet this figure represents a significant 29% year-over-year decline. Despite the revenue contraction, InMode has maintained its full-year guidance, suggesting confidence in its future outlook. The company's current valuation stands at a P/E ratio of 5.8, which InvestingPro analysis suggests is undervalued.

Analyst sentiment remains cautious, with Canaccord Genuity raising its price target to $16 from $14 but retaining a "Hold" rating, a stance echoed by Needham. Concurrently, significant shareholder DOMA Perpetual Capital Management is advocating for a substantial 20% share buyback across Q4 2025 and Q1 2026, signaling a belief in intrinsic value and a desire for capital return. These divergent views highlight the complex investment landscape for INMD.

Key Decisions for Investors

• Investors should closely monitor the impact of the new North American President and restructuring efforts on future revenue growth, particularly in light of the recent 29% year-over-year sales decline.
• Evaluate the company's ability to meet its maintained full-year guidance, considering the mixed signal of a Q3 revenue beat alongside significant year-over-year contraction.
• Assess the likelihood and potential impact of the proposed 20% share buyback by DOMA Perpetual Capital Management on shareholder returns and the company's capital structure.
• Consider the implications of analyst "Hold" ratings and the raised price target against the InvestingPro "undervalued" assessment when evaluating current positions or entry points.